For the year ending 2025-12-31, PEN had -$137,507K decrease in cash & cash equivalents over the period. $174,934K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 177,687 |
| Depreciation and amortization | 17,471 |
| Stock-based compensation | 59,213 |
| Impairment charge | 0 |
| Inventory write-offs and write-downs | 5,769 |
| Deferred taxes | 21,034 |
| Acquired in-process research and development | 0 |
| Other | 205 |
| Accounts receivable | 19,514 |
| Inventories | 26,482 |
| Prepaid expenses and other current and non-current assets | 12,697 |
| Accounts payable | 3,067 |
| Accrued expenses and other non-current liabilities | 12,910 |
| Proceeds from lease incentives | 0 |
| Net cash provided by operating activities | 238,663 |
| Asset acquisition, net of cash acquired | 0 |
| Purchases of non-marketable investments | 0 |
| Purchases of marketable investments | 355,737 |
| Proceeds from sales of marketable investments | 1,876 |
| Proceeds from maturities of marketable investments | 13,000 |
| Purchases of property and equipment | 63,729 |
| Other | 0 |
| Net cash (used in) provided by investing activities | -404,590 |
| Proceeds from exercises of stock options | 15,411 |
| Proceeds from issuance of stock under employee stock purchase plan | 16,408 |
| Payment of employee taxes related to vested common and restricted stock | 2,546 |
| Payments of finance lease obligations | 2,485 |
| Repurchase of common stock | 0 |
| Other | -256 |
| Net cash provided by (used in) financing activities | 26,532 |
| Effect of foreign exchange rate changes on cash and cash equivalents | 1,888 |
| Net (decrease) increase in cash and cash equivalents | -137,507 |
| Cash and cash equivalentsbeginning of period | 324,404 |
| Cash and cash equivalentsend of period | 186,897 |
Penumbra Inc (PEN)
Penumbra Inc (PEN)